Cargando…
The importance of clinician, patient and researcher collaborations in Alport syndrome
Alport syndrome is caused by mutations in the genes COL4A3, COL4A4 or COL4A5 and is characterised by progressive glomerular disease, sensorineural hearing loss and ocular defects. Occurring in less than 1:5000, Alport syndrome is a rare genetic disorder but still accounts for > 1% of the prevalen...
Autores principales: | Rheault, Michelle N., Savige, Judith, Randles, Michael J., Weinstock, André, Stepney, Melissa, Turner, A Neil, Parziale, Gina, Gross, Oliver, Flinter, Frances A, Miner, Jeffrey H, Lagas, Sharon, Gear, Susie, Lennon, Rachel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096363/ https://www.ncbi.nlm.nih.gov/pubmed/31044288 http://dx.doi.org/10.1007/s00467-019-04241-7 |
Ejemplares similares
-
The 2014 International Workshop on Alport Syndrome
por: Miner, Jeffrey H, et al.
Publicado: (2014) -
Clinical trial recommendations for potential Alport syndrome therapies
por: Weinstock, B. André, et al.
Publicado: (2020) -
The 2019 and 2021 International Workshops on Alport Syndrome
por: Daga, Sergio, et al.
Publicado: (2022) -
Advances and unmet needs in genetic, basic and clinical science in Alport syndrome: report from the 2015 International Workshop on Alport Syndrome
por: Gross, Oliver, et al.
Publicado: (2017) -
Genetic Modifiers of Mendelian Monogenic Collagen IV Nephropathies in Humans and Mice
por: Deltas, Constantinos, et al.
Publicado: (2023)